Prevention of primary bacteraemia

International Journal of Antimicrobial Agents

Volumn 30, Issue SUPPL. 1, 2007, Pages 80-87

  Juan Torres, Antoni ^a   Harbarth, Stephan ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Catheterisation; Central venous catheter; Cross infection; Guideline adherence; Patient care; Practice guidelines; Prevention control; Prospective studies; Septicaemia

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; CANDIDA; CATHETER INFECTION; COMMUNICABLE DISEASE; CROSS INFECTION; ESCHERICHIA COLI; HIGH RISK POPULATION; HUMAN; HYGIENE; KLEBSIELLA; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

BACTEREMIA; CATHETERS, INDWELLING; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; INFECTION CONTROL; VACCINES;

EID: 34848820580     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.06.021     Document Type: Article

References (42)

1. Hugonnet S., Harbarth S., Ferriere K., Ricou B., Suter P., and Pittet D. Bacteremic sepsis in intensive care: temporal trends in incidence, organ dysfunction, and prognosis. Crit Care Med 31 (2003) 390-394
2. Eggimann P., and Pittet D. Overview of catheter-related infections with special emphasis on prevention based on educational programs. Clin Microbiol Infect 8 (2002) 295-309
3. Pedersen G., Schonheyder H.C., and Sorensen H.T. Source of infection and other factors associated with case fatality in community-acquired bacteremia - a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect 9 (2003) 793-802
4. Alberti C., Brun-Buisson C., Burchardi H., et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28 (2002) 108-121
5. Harbarth S., Ferriere K., Hugonnet S., Ricou B., Suter P., and Pittet D. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg 137 (2002) 1353-1359
6. Renaud B., and Brun-Buisson C. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163 (2001) 1584-1590
7. Rosenthal V.D., Maki D.G., Salomao R., et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 145 (2006) 582-591
8. Harbarth S., Nobre V., and Pittet D. Does antibiotic selection impact patient outcome?. Clin Infect Dis 44 (2007) 87-93
9. Shinefield H., Black S., Fattom A., et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 346 (2002) 491-496
10. Roth D.M., Senna J.P., and Machado D.C. Evaluation of the humoral immune response in BALB/c mice immunized with a naked DNA vaccine anti-methicillin-resistant Staphylococcus aureus. Genet Mol Res 5 (2006) 503-512
11. Poehling K.A., Talbot T.R., Griffin M.R., et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 295 (2006) 1668-1674
12. Liappis A.P., Kan V.L., Rochester C.G., and Simon G.L. The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 33 (2001) 1352-1357
13. Kruger P., Fitzsimmons K., Cook D., Jones M., and Nimmo G. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med 32 (2006) 75-79
14. Corona A., Raimondi F., and Singer M. Statin use and mortality in the bacteremic critically ill patient. Crit Care Med 34 (2006) 1270-1272
15. Harbarth S., Sax H., and Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 54 (2003) 258-266
16. Maki D.G., and Mermel L.A. Infections due to infusion therapy. In: Bennett J.V., and Brachman P.S. (Eds). Hospital infections. 4th edition (1998), Lippincott-Raven, Philadelphia, PA 689-724
17. Chaiyakunapruk N., Veenstra D.L., Lipsky B.A., and Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 136 (2002) 792-801
18. Eggimann P., Sax H., and Pittet D. Catheter-related infections. Microbes Infect 6 (2004) 1033-1042
19. Elliott T. Intravascular catheter-related sepsis - novel methods of prevention. Intensive Care Med 26 Suppl 1 (2000) S45-S50
20. Zuschneid I., Schwab F., Geffers C., Ruden H., and Gastmeier P. Reducing central venous catheter-associated primary bloodstream infections in intensive care units is possible: data from the German nosocomial infection surveillance system. Infect Control Hosp Epidemiol 24 (2003) 501-505
21. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51 (2002) 1-29
22. Eggimann P., Harbarth S., Constantin M.N., Touveneau S., Chevrolet J.C., and Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 355 (2000) 1864-1868
23. Eggimann P., Hugonnet S., Sax H., Harbarth S., Chevrolet J.C., and Pittet D. Long-term reduction of vascular access-associated bloodstream infection. Ann Intern Med 142 (2005) 875-876
24. Berenholtz S.M., Pronovost P.J., Lipsett P.A., et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 32 (2004) 2014-2020
25. Hu K.K., Veenstra D.L., Lipsky B.A., and Saint S. Use of maximal sterile barriers during central venous catheter insertion: clinical and economic outcomes. Clin Infect Dis 39 (2004) 1441-1445
26. Reduction in central line-associated bloodstream infections among patients in intensive care units - Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1013-16.
27. Berwick D.M., Calkins D.R., McCannon C.J., and Hackbarth A.D. The 100,000 lives campaign: setting a goal and a deadline for improving health care quality. JAMA 295 (2006) 324-327
28. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 (2006) 2725-2732
29. Veenstra D.L., Saint S., Saha S., Lumley T., and Sullivan S.D. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281 (1999) 261-267
30. Ranucci M., Isgro G., Giomarelli P.P., et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 31 (2003) 52-59
31. Rupp M.E., Lisco S.J., Lipsett P.A., et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 143 (2005) 570-580
32. Osma S., Kahveci S.F., Kaya F.N., et al. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit. J Hosp Infect 62 (2006) 156-162
33. Fraenkel D., Rickard C., Thomas P., Faoagali J., George N., and Ware R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 34 (2006) 668-675
34. Borschel D.M., Chenoweth C.E., Kaufman S.R., et al. Are antiseptic-coated central venous catheters effective in a real-world setting?. Am J Infect Control 34 (2006) 388-393
35. Dunser M.W., Mayr A.J., Hinterberger G., et al. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters. Anesth Analg 101 (2005) 1778-1784
36. Shorr A.F., Humphreys C.W., and Helman D.L. New choices for central venous catheters: potential financial implications. Chest 124 (2003) 275-284
37. Marciante K.D., Veenstra D.L., Lipsky B.A., and Saint S. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. Am J Infect Control 31 (2003) 1-8
38. Brun-Buisson C., Doyon F., Sollet J.P., Cochard J.F., Cohen Y., and Nitenberg G. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med 30 (2004) 837-843
39. Fortun J., Grill F., Martin-Davila P., et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 58 (2006) 816-821
40. Safdar N., and Maki D.G. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 43 (2006) 474-484
41. Sherertz R.J., Boger M.S., Collins C.A., Mason L., and Raad I.I. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 50 (2006) 1865-1868
42. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36 (2003) 1539-1544